AEP cleaves Tau in vitro and in human Alzheimer’s disease (AD) brains, abolishing its microtubule stabilizing function, inducing Tau aggregation, and triggering neurodegeneration (Zhang et al., 2014). Here, MAPT is linked to Alzheimer disease.